Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

2.

Reply to van Gerpen and Hassan comment on "Orthostatic myoclonus after brain tumor radiation: Insights from two lesional cases".

Cutsforth-Gregory JK, Hammack JE, Matsumoto JY.

Parkinsonism Relat Disord. 2017 Nov;44:158. doi: 10.1016/j.parkreldis.2017.08.024. Epub 2017 Sep 1. No abstract available.

PMID:
28874311
3.

Orthostatic myoclonus after brain tumor radiation: Insights from two lesional cases.

Cutsforth-Gregory JK, Hammack JE, Matsumoto JY.

Parkinsonism Relat Disord. 2017 Aug;41:109-112. doi: 10.1016/j.parkreldis.2017.04.015. Epub 2017 Apr 26.

PMID:
28457650
4.

Precise stimulation location optimizes speech outcomes in essential tremor.

Matsumoto JY, Fossett T, Kim M, Duffy JR, Strand E, McKeon A, Lee KH, Stead M, Burnett M, Adams AC, Klassen BT.

Parkinsonism Relat Disord. 2016 Nov;32:60-65. doi: 10.1016/j.parkreldis.2016.08.017. Epub 2016 Aug 25.

PMID:
27595548
5.

Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

Benito-León J, Domingo-Santos A, Hassan A, Ahlskog JE, Matsumoto JY, Bower JH.

Neurology. 2016 Jul 19;87(3):341. doi: 10.1212/WNL.0000000000002907. No abstract available.

PMID:
27432180
6.

Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates.

Abulseoud OA, Kasasbeh A, Min HK, Fields JA, Tye SJ, Goerss S, Knight EJ, Sampson SM, Klassen BT, Matsumoto JY, Stoppel C, Lee KH, Frye MA.

Stereotact Funct Neurosurg. 2016;94(2):93-101. doi: 10.1159/000445076. Epub 2016 Apr 20.

7.

Repetitive exercise dystonia: A difficult to treat hazard of runner and non-runner athletes.

Cutsforth-Gregory JK, Ahlskog JE, McKeon A, Burnett MS, Matsumoto JY, Hassan A, Bower JH.

Parkinsonism Relat Disord. 2016 Jun;27:74-80. doi: 10.1016/j.parkreldis.2016.03.013. Epub 2016 Mar 18.

PMID:
27017145
8.

Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

Hassan A, Ahlskog JE, Matsumoto JY, Milber JM, Bower JH, Wilkinson JR.

Neurology. 2016 Feb 2;86(5):458-64. doi: 10.1212/WNL.0000000000002328. Epub 2016 Jan 8.

PMID:
26747880
9.

Clinical features and autonomic testing predict survival in multiple system atrophy.

Coon EA, Sletten DM, Suarez MD, Mandrekar JN, Ahlskog JE, Bower JH, Matsumoto JY, Silber MH, Benarroch EE, Fealey RD, Sandroni P, Low PA, Singer W.

Brain. 2015 Dec;138(Pt 12):3623-31. doi: 10.1093/brain/awv274. Epub 2015 Sep 13.

10.

Gamma oscillations precede interictal epileptiform spikes in the seizure onset zone.

Ren L, Kucewicz MT, Cimbalnik J, Matsumoto JY, Brinkmann BH, Hu W, Marsh WR, Meyer FB, Stead SM, Worrell GA.

Neurology. 2015 Feb 10;84(6):602-8. doi: 10.1212/WNL.0000000000001234. Epub 2015 Jan 14.

11.

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A.

Neurology. 2014 Nov 11;83(20):1797-803. doi: 10.1212/WNL.0000000000000991. Epub 2014 Oct 15.

12.

High frequency oscillations are associated with cognitive processing in human recognition memory.

Kucewicz MT, Cimbalnik J, Matsumoto JY, Brinkmann BH, Bower MR, Vasoli V, Sulc V, Meyer F, Marsh WR, Stead SM, Worrell GA.

Brain. 2014 Aug;137(Pt 8):2231-44. doi: 10.1093/brain/awu149. Epub 2014 Jun 11.

13.

Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study.

Chopra A, Abulseoud OA, Sampson S, Lee KH, Klassen BT, Fields JA, Matsumoto JY, Adams AC, Stoppel CJ, Geske JR, Frye MA.

Psychosomatics. 2014 Sep-Oct;55(5):478-84. doi: 10.1016/j.psym.2013.09.003. Epub 2013 Dec 21.

14.

Childhood onset of stiff-man syndrome.

Clardy SL, Lennon VA, Dalmau J, Pittock SJ, Jones HR Jr, Renaud DL, Harper CM Jr, Matsumoto JY, McKeon A.

JAMA Neurol. 2013 Dec;70(12):1531-6. doi: 10.1001/jamaneurol.2013.4442. Review.

15.

Lack of differential motor outcome with subthalamic nucleus region stimulation in Parkinson's disease.

Kasasbeh A, Abulseoud OA, Matsumoto JY, Stead SM, Goerss SJ, Klassen BT, Huston J 3rd, Min HK, Lee KH, Frye MA.

J Clin Neurosci. 2013 Nov;20(11):1520-6. doi: 10.1016/j.jocn.2013.02.006. Epub 2013 Jul 29.

PMID:
23906524
16.

Network oscillations modulate interictal epileptiform spike rate during human memory.

Matsumoto JY, Stead M, Kucewicz MT, Matsumoto AJ, Peters PA, Brinkmann BH, Danstrom JC, Goerss SJ, Marsh WR, Meyer FB, Worrell GA.

Brain. 2013 Aug;136(Pt 8):2444-56. doi: 10.1093/brain/awt159. Epub 2013 Jun 25.

17.

Autoimmune chorea in adults.

O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A.

Neurology. 2013 Mar 19;80(12):1133-44. doi: 10.1212/WNL.0b013e3182886991. Epub 2013 Feb 20.

18.

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.

McKeon A, Martinez-Hernandez E, Lancaster E, Matsumoto JY, Harvey RJ, McEvoy KM, Pittock SJ, Lennon VA, Dalmau J.

JAMA Neurol. 2013 Jan;70(1):44-50. doi: 10.1001/jamaneurol.2013.574.

19.

Adult-onset opsoclonus-myoclonus syndrome.

Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, Kumar R, McEvoy KF, McKeon A.

Arch Neurol. 2012 Dec;69(12):1598-607. doi: 10.1001/archneurol.2012.1173.

PMID:
22986354
20.

Stiff-man syndrome and variants: clinical course, treatments, and outcomes.

McKeon A, Robinson MT, McEvoy KM, Matsumoto JY, Lennon VA, Ahlskog JE, Pittock SJ.

Arch Neurol. 2012 Feb;69(2):230-8. doi: 10.1001/archneurol.2011.991.

PMID:
22332190
21.

Surgical therapy for multiple sclerosis tremor: a 12-year follow-up study.

Hassan A, Ahlskog JE, Rodriguez M, Matsumoto JY.

Eur J Neurol. 2012 May;19(5):764-8. doi: 10.1111/j.1468-1331.2011.03626.x. Epub 2012 Jan 17.

PMID:
22248187
22.

Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.

Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):453-9. doi: 10.1136/jnnp-2011-301068. Epub 2012 Jan 6.

23.

Moving forward: advances in the treatment of movement disorders with deep brain stimulation.

Schiefer TK, Matsumoto JY, Lee KH.

Front Integr Neurosci. 2011 Nov 9;5:69. doi: 10.3389/fnint.2011.00069. eCollection 2011.

24.

Clinical failure of botulinum toxin A in movement disorders.

Savica R, Grossardt BR, Bower JH, Klassen BT, Matsumoto JY.

Parkinsonism Relat Disord. 2012 Jan;18(1):73-5. doi: 10.1016/j.parkreldis.2011.07.016. Epub 2011 Aug 30.

PMID:
21880538
25.

Parkinsonism and dropped head: dystonia, myopathy or both?

Savica R, Kumar N, Ahlskog JE, Josephs KA, Matsumoto JY, McKeon A.

Parkinsonism Relat Disord. 2012 Jan;18(1):30-4. doi: 10.1016/j.parkreldis.2011.08.006. Epub 2011 Aug 27.

PMID:
21873101
26.

Deep brain stimulation in benign tremulous parkinsonism.

Savica R, Matsumoto JY, Josephs KA, Ahlskog JE, Stead M, Lee KH, Klassen BT.

Arch Neurol. 2011 Aug;68(8):1033-6. doi: 10.1001/archneurol.2011.160.

PMID:
21825239
27.

SPECT perfusion patterns distinguish psychogenic from essential tremor.

Czarnecki K, Jones DT, Burnett MS, Mullan B, Matsumoto JY.

Parkinsonism Relat Disord. 2011 Jun;17(5):328-32. doi: 10.1016/j.parkreldis.2011.01.012. Epub 2011 Feb 12.

PMID:
21317018
28.

Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.

Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE.

Parkinsonism Relat Disord. 2011 May;17(4):260-4. doi: 10.1016/j.parkreldis.2011.01.009. Epub 2011 Feb 9. Erratum in: Parkinsonism Relat Disord. 2011 Jul;17(6):499.

PMID:
21310646
29.

Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri).

Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA.

Arch Neurol. 2010 Sep;67(9):1109-15. doi: 10.1001/archneurol.2010.209.

PMID:
20837856
30.

Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia.

Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN.

Pediatr Neurol. 2010 Jul;43(1):46-8. doi: 10.1016/j.pediatrneurol.2010.03.013.

PMID:
20682203
31.

Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease.

McKeon A, Ahlskog JE, Bower JH, Josephs KA, Matsumoto JY.

Mov Disord. 2009 Jan 15;24(1):72-6. doi: 10.1002/mds.22301.

PMID:
18831532
32.

Psychogenic tremor occurring after deep brain stimulation surgery for essential tremor.

McKeon A, Ahlskog JE, Matsumoto JY.

Neurology. 2008 Apr 15;70(16 Pt 2):1498-9. doi: 10.1212/01.wnl.0000310429.30886.bc. No abstract available.

PMID:
18413577
33.

The spectrum of disorders presenting as adult-onset focal lower extremity dystonia.

McKeon A, Matsumoto JY, Bower JH, Ahlskog JE.

Parkinsonism Relat Disord. 2008 Dec;14(8):613-9. doi: 10.1016/j.parkreldis.2008.01.012. Epub 2008 Mar 7.

PMID:
18329318
34.

Orthostatic myoclonus: a contributor to gait decline in selected elderly.

Glass GA, Ahlskog JE, Matsumoto JY.

Neurology. 2007 May 22;68(21):1826-30. Epub 2007 Mar 14.

PMID:
17360964
35.

Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales.

Elble RJ, Pullman SL, Matsumoto JY, Raethjen J, Deuschl G, Tintner R; Tremor Research Group.

Brain. 2006 Oct;129(Pt 10):2660-6. Epub 2006 Aug 3.

PMID:
16891320
36.

Benign tremulous parkinsonism.

Josephs KA, Matsumoto JY, Ahlskog JE.

Arch Neurol. 2006 Mar;63(3):354-7.

PMID:
16533962
37.

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.

Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE.

Parkinsonism Relat Disord. 2005 Sep;11(6):381-6.

PMID:
16109498
38.

Heterozygous Niemann-Pick disease type C presenting with tremor.

Josephs KA, Matsumoto JY, Lindor NM.

Neurology. 2004 Dec 14;63(11):2189-90. No abstract available.

PMID:
15596783
39.

Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.

Pittock SJ, McClelland RL, Mayr WT, Rodriguez M, Matsumoto JY.

Mov Disord. 2004 Dec;19(12):1482-5.

PMID:
15390075
40.

Multidirectional neck strength and electromyographic activity for normal controls.

Gabriel DA, Matsumoto JY, Davis DH, Currier BL, An KN.

Clin Biomech (Bristol, Avon). 2004 Aug;19(7):653-8.

PMID:
15288449
41.

Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project.

Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED.

Mov Disord. 2004 May;19(5):529-33.

PMID:
15133816
42.

Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm.

Mokri B, Ahlskog JE, Fulgham JR, Matsumoto JY.

Neurology. 2004 Mar 23;62(6):971-3.

PMID:
15037703
43.

Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, Schmeichel AM, Smith GE, Petersen RC, Ahlskog JE, Matsumoto JY, Knopman DS, Schenck CH, Mahowald MW.

Neurology. 2003 Jul 8;61(1):40-5.

PMID:
12847154
44.

Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic.

Cohen-Gadol AA, Ahlskog JE, Matsumoto JY, Swenson MA, McClelland RL, Davis DH.

J Neurosurg. 2003 Jun;98(6):1247-54.

PMID:
12816272
45.

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.

Brin MF, Lyons KE, Doucette J, Adler CH, Caviness JN, Comella CL, Dubinsky RM, Friedman JH, Manyam BV, Matsumoto JY, Pullman SL, Rajput AH, Sethi KD, Tanner C, Koller WC.

Neurology. 2001 Jun 12;56(11):1523-8.

PMID:
11402109
46.

Utility of an EMG mapping study in treating cervical dystonia.

Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG.

Muscle Nerve. 2000 Nov;23(11):1752-6.

PMID:
11054755
47.

Anesthetic management for two-stage computer-assisted, stereotactic thalamotomy in a child with Hallervorden-Spatz Disease.

Keegan MT, Flick RP, Matsumoto JY, Davis DH, Lanier WL.

J Neurosurg Anesthesiol. 2000 Apr;12(2):107-11.

PMID:
10774604
48.

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL.

Mov Disord. 1999 Nov;14(6):940-6.

PMID:
10584667
49.

Facial trigeminal synkinesis associated with a trigeminal schwannoma.

Rubin DI, Matsumoto JY, Suarez GA, Auger RG.

Neurology. 1999 Aug 11;53(3):635-7.

PMID:
10449135
50.

Cortical potentials at the frequency of absolute wrist velocity become phase-locked during slow sinusoidal tracking movements.

O'Suilleabhain PE, Lagerlund TD, Matsumoto JY.

Exp Brain Res. 1999 Jun;126(4):529-35.

PMID:
10422716

Supplemental Content

Loading ...
Support Center